A newly surfaced internal memo from the U.S. Food and Drug Administration (FDA) has sparked debate after chief medical and scientific officer Vinay Prasad stated that COVID-19 vaccinations may have contributed to at least 10 cases of fatal heart inflammation in children. According to the memo, seen by Reuters, Prasad said the staff’s preliminary review suggested “likely, probable, or possible” vaccine attribution in these deaths. He described the findings as significant, noting it would mark the first time the FDA acknowledged potential fatal vaccine-related cases in American children.
The analysis reviewed 96 child deaths reported between 2021 and 2024. While it did not identify the children’s underlying medical conditions or the vaccine manufacturers involved, Prasad said that the early assessment found no fewer than 10 cases potentially linked to COVID-19 vaccination. He added that examining deaths involving children aged 7 to 16 was especially difficult.
Health Secretary Robert F. Kennedy Jr. has recently shifted U.S. vaccine policy, restricting access to COVID-19 vaccines to individuals 65 and older and those with certain conditions. Kennedy, long known for his skepticism toward vaccines, has criticized past vaccine policies promoted under both the Trump and Biden administrations.
Experts have urged caution in interpreting the memo. The FDA’s assessment has not been peer-reviewed or published in a medical journal, and critics—including UC Law San Francisco professor Dorit Reiss—argue that policy changes should not stem from unpublished investigations. Reiss also noted Prasad is not a vaccine specialist.
Despite concerns raised in the memo, FDA Commissioner Marty Makary emphasized that COVID-19 vaccines were highly effective for older adults, especially when matched to circulating variants. Recent research also supports the benefits of updated vaccines in reducing severe illness and hospitalization among high-risk groups.
CDC data shows 1,071 U.S. children aged 5 to 18 died from COVID-19 between early 2020 and mid-2023. Prasad argued that it remains unclear how vaccination influenced those outcomes, stating that voluntary reporting and unknown prevention metrics complicate comparisons.
The memo is expected to fuel continued discussion ahead of an upcoming CDC vaccine committee meeting.


Hantavirus Cruise Ship Outbreak Triggers Global Health Alert
Brazil Pension Fund Crackdown After Banco Master Collapse Raises Investment Concerns
U.S. Fast-Tracks $8.6 Billion Arms Sales to Middle East Allies Amid Rising Tensions
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales
Panama Defends Port Takeover Amid U.S.-China Tensions and Canal Dispute
CDC Acting Director Urges Measles Vaccination as U.S. Cases Surge in 2026
Trump Invites Top CEOs Including Nvidia, Apple, Boeing to China Summit With Xi Jinping
Pope Leo Calls for Peace as Vatican Seeks Better Ties With U.S.
Supreme Court Asked to Reinstate Mail-Order Access to Abortion Pill Mifepristone
Novo Nordisk Raises 2026 Outlook on Strong Wegovy Demand
Intermittent fasting doesn’t have an edge for weight loss, but might still work for some
US Sanctions Target Iran’s Shadow Banking Network and Terror Financing
US Adds European Union to Section 301 Watchlist Amid Trade Concerns
Trump Reportedly Approves Plan to Remove FDA Commissioner Marty Makary Amid Growing Controversies
US Revises UN Resolution on Iran Strait of Hormuz Attacks Amid Russia-China Opposition
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Democratic Attorneys General Sue Trump Administration Over CDC Childhood Vaccine Schedule Changes 



